Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Molecules ; 25(4)2020 Feb 14.
Article in English | MEDLINE | ID: mdl-32075008

ABSTRACT

Haemostatic disorders are both complex and costly in relation to both their treatment and subsequent management. As leading causes of mortality worldwide, there is an ever-increasing drive to improve the diagnosis and prevention of haemostatic disorders. The field of microfluidic and Lab on a Chip (LOC) technologies is rapidly advancing and the important role of miniaturised diagnostics is becoming more evident in the healthcare system, with particular importance in near patient testing (NPT) and point of care (POC) settings. Microfluidic technologies present innovative solutions to diagnostic and clinical challenges which have the knock-on effect of improving health care and quality of life. In this review, both advanced microfluidic devices (R&D) and commercially available devices for the diagnosis and monitoring of haemostasis-related disorders and antithrombotic therapies, respectively, are discussed. Innovative design specifications, fabrication techniques, and modes of detection in addition to the materials used in developing micro-channels are reviewed in the context of application to the field of haemostasis.


Subject(s)
Biosensing Techniques , Hemostasis , Hemostatic Disorders/diagnosis , Microfluidics/methods , Hemostatic Disorders/pathology , Humans , Lab-On-A-Chip Devices , Point-of-Care Systems , Quality of Life
2.
Micromachines (Basel) ; 10(9)2019 Sep 10.
Article in English | MEDLINE | ID: mdl-31510027

ABSTRACT

A new method, a 3D printing technique, in particular, selective laser melting (SLM), has been used to fabricate moulds for the injection moulding of thermoplastic microfluidic chips that are suitable for prototyping and early stage scale-up. The micro metallic patterns are printed on to a pre-finished substrate to form a microstructured mould. The dimensional accuracy, surface morphology, bonding strength between the printed patterns and substrate, as well as the microstructure of micro features were all characterized. A microfluidic mould was successfully printed and used directly for injection moulding of cyclic olefin copolymer (COC) microfluidic chips, which were used subsequently to successfully monitor nitrite concentrations in environmental water. The characterization indicated that this new process can be used for fast fabrication of mould tools for injection moulding/hot embossing microfluidic devices. It is faster, more flexible and less expensive than conventional micro-machining processes, although the accuracy and finish are still needed to improve though process optimization and hybrid SLM and machining processes.

3.
Langmuir ; 32(11): 2820-8, 2016 Mar 22.
Article in English | MEDLINE | ID: mdl-26910300

ABSTRACT

We report the development of a microfluidic device for the rapid assay in whole blood of interfacial platelet-protein interactions indicative of the efficacy of antiplatelet drugs, for example, aspirin and Plavix, two of the world's most widely used drugs, in patients with cardiovascular disease (CVD). Because platelet adhesion to surface-confined protein matrices is an interfacial phenomenon modulated by fluid shear rates at the blood/protein interface, and because such binding is a better indicator of platelet function than platelet self-aggregation, we designed, fabricated, and characterized the performance of a family of disposable, self-powered microfluidic chips with well-defined flow and interfacial shear rates suitable for small blood volumes (≤200 µL). This work demonstrates that accurate quantification of cell adhesion to protein matrices, an important interfacial biological phenomenon, can be used as a powerful diagnostic tool in those with CVD, the world's leading cause of death. To enable such measurements, we developed a simple technique to fabricate single-use self-powered chips incorporating shear control (SpearChips). These parallel-plate flow devices integrate on-chip vacuum-driven blood flow, using a predegassed elastomer component to obviate active pumping, with microcontact-printed arrays of 6-µm-diameter fluorescently labeled fibrinogen dots on a cyclic olefin polymer base plate as a means to quantitatively count platelet-protein binding events. The use of SpearChips to assess in whole blood samples the effects of GPIIb/IIIa and P2Y12 inhibitors, two important classes of "antiplatelet" drugs, is reported.


Subject(s)
Equipment Design/instrumentation , Lab-On-A-Chip Devices , Platelet Aggregation Inhibitors/blood , Abciximab , Adenosine/analogs & derivatives , Adenosine/blood , Adenosine Monophosphate/analogs & derivatives , Adenosine Monophosphate/blood , Animals , Antibodies, Monoclonal/blood , Cattle , Clopidogrel , Dimethylpolysiloxanes , Fibrinogen , Humans , Immunoglobulin Fab Fragments/blood , Platelet Glycoprotein GPIIb-IIIa Complex/antagonists & inhibitors , Powders , Prasugrel Hydrochloride/blood , Purinergic P2Y Receptor Antagonists/blood , Serum Albumin, Bovine , Ticagrelor , Ticlopidine/analogs & derivatives , Ticlopidine/blood
4.
IEEE Trans Biomed Eng ; 59(2): 374-82, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22020664

ABSTRACT

We report the development of an aqueous buffer system tailored to the fluidic and hemodynamic requirements of our recently reported microfluidic platelet dynamic assay device, which uses hydrodynamic focusing to "shape" a blood sample into a thin flowing layer adjacent to its protein-functionalized surface. By matching the dynamic viscosity of whole blood (3.13 ± 0.08 mPa·s, from healthy donors), the selected buffer minimizes interfacial fluid mixing and better controls shear rate within the device, permitting platelet/protein-surface interaction assays with as little as 50 µL of whole blood. Buffers containing the viscosity-enhancing components bovine serum albumin (BSA), gelofusine/glycine, or histopaque (Ficoll gradient solution) were found not to activate platelets when incubated with blood at concentrations up to 50%, as assessed by flow cytometry quantitation of P-selectin expression and αIIbß (3) activation. In contrast, glycerol-based buffer activated platelets (two-fold increase in P-selectin levels) at concentrations as low as 10% by volume. BSA- and gelofusine/glycine-based buffers were problematic in preparation and use, and therefore, were not used beyond initial characterization. The histopaque solution selected as the best choice for flow studies stabilizes sample contact with the device's thrombogenic surface, does not activate platelets, and does not interfere with the action of agonists added to deliberately activate platelets.


Subject(s)
Blood Platelets/physiology , Blood Viscosity/physiology , Microfluidic Analytical Techniques/instrumentation , Microfluidic Analytical Techniques/methods , Animals , Blood Coagulation Factors/physiology , Buffers , Cattle , Diatrizoate , Ficoll , Flow Cytometry , Gelatin/chemistry , Glycine/chemistry , Humans , Mice , Microscopy, Fluorescence , Platelet Function Tests/instrumentation , Platelet Function Tests/methods , Serum Albumin, Bovine/chemistry , Succinates/chemistry
5.
Analyst ; 136(9): 1816-25, 2011 May 07.
Article in English | MEDLINE | ID: mdl-21293802

ABSTRACT

Microfluidic devices and microsystems have been used to develop blood coagulation monitoring devices for point of care diagnostic use. However, many of them suffer from inherent variability and imprecision, partly due to the fact that they only detect changes in bulk clotting properties and do not reflect the microscopic nature of blood coagulation. This work demonstrates microstructured lateral flow platforms used in combination with fluorescently labelled fibrinogen to detect microscopic clot formation. Plasma samples applied to platforms modified with coagulation activation reagents and fluorescent fibrinogen produced changes in fluorescence intensity due to incorporation of the fluorophore into the forming microclots. It was found that the change in the distribution of the fluorescence within the sample over time was an excellent predictor of the onset of coagulation, which could be used to determine the clotting time. The impact of various assay parameters was optimised and the assay was shown to be capable of measuring the effect of heparin concentration on blood clotting time from 0 to 1.5 U mL(-1).


Subject(s)
Blood Coagulation Tests/methods , Blood Coagulation , Fluorescent Dyes/metabolism , Plasma/chemistry , Anticoagulants/pharmacology , Evaluation Studies as Topic , Fibrinogen/chemistry , Heparin/chemistry , Humans
6.
IEEE Trans Biomed Eng ; 58(3): 826-30, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21342809

ABSTRACT

We report a microfluidic chip-based hydrodynamic focusing approach that minimizes sample volume for the analysis of cell-surface interactions under controlled fluid-shear conditions. Assays of statistically meaningful numbers of translocating platelets interacting with immobilized von Willebrand factor at arterial shear rates (∼1500 s(-1)) are demonstrated. By controlling spatial disposition and relative flow rates of two contacting fluid streams, e.g., sample (blood) and aqueous buffer, on-chip hydrodynamic focusing guides the cell-containing stream across the protein surface as a thin fluid layer, consuming ∼50 µL of undiluted whole blood for a 2-min platelet assay. Control of wall shear stress is independent of sample consumption for a given flow time. The device design implements a mass-manufacturable fabrication approach. Fluorescent labeling of cells enables readout using standard microscopy tools. Customized image-analysis software rapidly quantifies cellular surface coverage and aggregate size distributions as a function of time during blood-flow analyses, facilitating assessment of drug treatment efficacy or diagnosis of disease state.


Subject(s)
Blood Platelets/cytology , Microfluidic Analytical Techniques/instrumentation , Platelet Adhesiveness/physiology , Point-of-Care Systems , Blood Platelets/chemistry , Blood Platelets/metabolism , Humans , Image Processing, Computer-Assisted , Immobilized Proteins/chemistry , Immobilized Proteins/metabolism , Platelet Function Tests/instrumentation , Platelet Function Tests/methods , Shear Strength , von Willebrand Factor/chemistry , von Willebrand Factor/metabolism
7.
Biomed Microdevices ; 12(6): 987-1000, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20652753

ABSTRACT

We report a novel device to analyze cell-surface interactions under controlled fluid-shear conditions on well-characterised protein surfaces. Its performance is demonstrated by studying platelets interacting with immobilised von Willebrand Factor at arterial vascular shear rates using just 200 µL of whole human blood per assay. The device's parallel-plate flow chamber, with 0.1 mm² cross sectional area and height-to-width ratio of 1:40, provides uniform, well-defined shear rates along the chip surface with negligible vertical wall effects on the fluid flow profile while minimizing sample volumetric flow. A coating process was demonstrated by ellipsometry, atomic force microscopy, and fluorescent immunostaining to provide reproducible, homogeneous, uniform protein layers over the 0.7 cm² cell-surface interaction area. Customized image processing quantifies dynamic cellular surface coverage vs. time throughout the whole-blood-flow assay for a given drug treatment or disease state. This device can track the dose response of anti-platelet drugs, is suitable for point-of-care diagnostics, and is designed for adaptation to mass manufacture.


Subject(s)
Arteries/cytology , Arteries/metabolism , Blood Platelets/cytology , Blood Platelets/metabolism , Blood Proteins/metabolism , Mechanical Phenomena , Microfluidic Analytical Techniques/instrumentation , Animals , Animals, Newborn , Antibodies/immunology , Arteries/physiology , Biomechanical Phenomena , Blood Platelets/physiology , Blood Proteins/immunology , Blood Volume , Equipment Design , Humans , Image Processing, Computer-Assisted , Mice , Microscopy, Atomic Force , Platelet Adhesiveness , Protein Binding , Reproducibility of Results , Software , von Willebrand Factor/metabolism
8.
Anal Biochem ; 405(2): 174-83, 2010 Oct 15.
Article in English | MEDLINE | ID: mdl-20513436

ABSTRACT

We report an integrated platelet translocation analysis system that measures complex dynamic platelet-protein surface interactions in microliter volumes of unmodified anticoagulated whole blood under controlled fluid shear conditions. The integrated system combines customized platelet-tracking image analysis with a custom-designed microfluidic parallel plate flow chamber and defined von Willebrand factor surfaces to assess platelet trajectories. Using a position-based probability function that accounts for image noise and preference for downstream movement, outputs include instantaneous and mean platelet velocities, periods of motion and stasis, and bond dissociation kinetics. Whole blood flow data from healthy donors at an arterial shear rate (1500 s(-1)) show mean platelet velocities from 8.9+/-1.0 to 12+/-4 microm s(-1). Platelets in blood treated with the antiplatelet agent c7E-Fab fragment spend more than twice as much time in motion as platelets from untreated control blood; the bond dissociation rate constant (k(off)) increases 1.3-fold, whereas mean translocation velocities do not differ. Blood from healthy unmedicated donors was used to assess flow assay reproducibility, donor variability, and the effects of antiplatelet treatment. This integrated system enables reliable, rapid populational quantification of platelet translocation under pathophysiological vascular fluid shear using as little as 150 microl of blood.


Subject(s)
Blood Platelets/metabolism , von Willebrand Factor/metabolism , Blood Platelets/cytology , Humans , Kinetics , Platelet Adhesiveness , Platelet Aggregation , Platelet Count , Stress, Mechanical , von Willebrand Factor/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL
...